Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Precision BioSciences
302 East Pettigrew St.
Dibrell Building Suite A-100
Durham, NC 27701
Phone: 919-314-5512
www.precisionbiosciences.com

Precision BioSciences' mission is to translate the world's most powerful genome editing technology into greatly needed products throughout the life sciences. Precision's proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Key Contact
Name
Matthew Kane
Title
CEO
Funding Events

Date
Amount
Type
Investors
05/11/15 $25,600,000 Series A Amgen Ventures
Baxter Ventures
Longevity Fund
VenBio
06/28/18 $110,000,000 Series B Adage Capital Management
Alexandria Real Estate Equities
ArrowMark Partners
Brace Pharma
Cormorant Asset Management
Cowen Investments
Franklin Templeton
Gilead Sciences
Osage University Partners
Pontifax AgTech
Ridgeback Capital Management
Vivo Capital